Receive CAPC Designation
DEA 8-Hour Opioid and Substance Use Disorder Training
This Learning Pathway contains eight hours of AACME and ANCC accredited training in the management of opioid and substance use disorders required for all DEA-registered clinicians by The Medication Access and Training Expansion (MATE) Act. Visit the DEA Diversion Control website for complete instructions and an overview of this new requirement. Upon completion, learners will receive a downloadable certificate.
CAPC members, log in to complete the Pathway. Not sure if your organization is a member? Check here.
To learn more, after completing your eight hours of training, view CAPC's on-demand webinar How Opioid Use Disorder Intersects with Serious Illness and Chronic Pain and Case Review How to Screen for Opioid Use Disorder and Make Complex Opioid Decisions.
Course 4: Prescribing an Opioid
Learn how to decide on an appropriate opioid, route of delivery, and dose, and understand how to prescribe for incident and breakthrough pain.
Course 5: Practice Prescribing an Opioid
Practice prescribing initial opioid doses for different pain types and characteristics. Learn to adjust dosing as needed to manage pain effectively.
Course 6: Creating a Pain Treatment Plan and Monitoring Effectiveness
Learn to develop a pain treatment plan with realistic goals and proper documentation, and implement universal precautions to help with the risk of opioid use disorder.
Course 7: Advanced Opioid Prescribing: Converting to Long-Acting Opioids
Learn how to convert from short-acting to long-acting opioids, and calculate rescue doses for breakthrough pain using updated equianalgesic tools.
Course 8: Problems with Opioid Prescribing: Is it an Opioid Use Disorder?
Learn how to identify and diagnose opioid use disorder (OUD) and practice communicating with patients about OUD and pain management.
Course 9: Using Buprenorphine for Chronic Pain and Opioid Use Disorder
Determine which patients may benefit from buprenorphine as a treatment for pain and opioid use disorder (OUD), and learn how to transition patients to buprenorphine.
Download a PDF of this Learning Pathway
Download PDF
